Cargando…
Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways
BACKGROUND: Studies of insulin-like growth factor 1 (IGF-1) as a novel therapy for the treatment of cardiovascular diseases have proven promising. However, elevated IGF-1 levels have also been associated with poor patient outcomes in heart failure with reduced ejection fraction. IGF-1 therapy has ad...
Autores principales: | Huang, Kevin W., Wang, Ian H., Fu, Ping, Krum, Henry, Bach, Leon A., Wang, Bing H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349770/ https://www.ncbi.nlm.nih.gov/pubmed/34401470 http://dx.doi.org/10.1016/j.ijcha.2021.100852 |
Ejemplares similares
-
Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage
por: Liu, Shan, et al.
Publicado: (2017) -
Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling
por: Takeda, Norifumi, et al.
Publicado: (2011) -
Insulin-like 3 affects zebrafish spermatogenic cells directly and via Sertoli cells
por: Crespo, Diego, et al.
Publicado: (2021) -
Relaxin Family Member Insulin‐Like Peptide 6 Ameliorates Cardiac Fibrosis and Prevents Cardiac Remodeling in Murine Heart Failure Models
por: Maruyama, Sonomi, et al.
Publicado: (2018) -
3′,4′-Dihydroxyflavonol Antioxidant Attenuates Diastolic Dysfunction and Cardiac Remodeling in Streptozotocin-Induced Diabetic m(Ren2)27 Rats
por: Khong, Fay Lin, et al.
Publicado: (2011)